Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Analysis of CNV in the Genomes of the Marrow Cells of the Patients with AML Revealed That High Numbers of Aberrations Associate with Better Survival and Deletions with the Aberrant Expression of CD19 in the Leukemic Blasts

Emilia Jaskula, PhD, Janusz Lange, MD PhD, Monika Mordak-Domagala, MD, Mariola Sedzimirska, MD PhD, Marta Lemieszewska, Agnieszka Tarnowska, Helena Pakos, Anna Sobczynska-Konefal, Andrzej Lange, MD

Blood (2019) 134 (Supplement_1): 5164.

https://doi.org/10.1182/blood-2019-130316

Published: 2019

Journal Articles

Intra Bone Route of Donor Lymphocyte Infusions May Result with an Anti-Leukemic Effect Associated with an Accumulation of CD279+ Lymphocytes in the Marrow

Andrzej Lange, MD FRCP, Dr MDSci, Professor, Monika Mordak-Domagala, MD, Mariola Sedzimirska, MD PhD, Michalina Krydel, Helena Pakos, Jolanta Bochenska, Emilia Jaskula, PhD

Blood (2016) 128 (22): 5763.

https://doi.org/10.1182/blood.V128.22.5763.5763

Published: 2016

Journal Articles

Sorafenib Is Contributing to Salvage Chemotherapy and Is Effective Given Alone for Maintenance in AML FLT3 ITD Patients Relapsing Post Allo Hematopoietic Stem Cell Transplantation

Emilia Jaskula, PhD, Janusz Lange, MD PhD, Mariola Sedzimirska, MD PhD, Andrzej Lange, MD Dr MDSci., Professor

Blood (2014) 124 (21): 5265.

https://doi.org/10.1182/blood.V124.21.5265.5265

Published: 2014

Journal Articles

Essential Thrombocytosis Patients Have At Diagnosis Prevalence Of CD8+ and CD45RO+CCR7- Lymphocytes and High Proportions Of Double Positive IL-17+/CD15+ Cells In The Marrow Cell Population

Mariola Sedzimirska, MD, PhD, Aleksandra Klimczak, PhD, Emilia Jaskula, PhD, Dlubek Dorota, PhD, Andrzej Lange, MD, PhD

Blood (2013) 122 (21): 5261.

https://doi.org/10.1182/blood.V122.21.5261.5261

Published: 2013

Journal Articles

CMV and EBV Reactivation Post HSCT Impairs Survival of Patients If They Do Not Produce IgM Antibodies Againts These Viruses

Andrzej Lange, MD, DSci, Emilia Jaskula, PhD, Sylwia Mizia, MSci, Jolanta Bochenska, MSci, Janusz Lange, MD

Blood (2011) 118 (21): 4552.

https://doi.org/10.1182/blood.V118.21.4552.4552

Published: 2011

Journal Articles

CCL2 Chemokine Gene Expression in Lymph Nodes May Have Prognostic Value in Non-Hodgkin’s Lymphoma.

Grzegorz Mazur, MD, PhD, Ilona Kryczek, PhD, Tomasz Wrobel, MD,PhD, Dorota Dlubek, MD,PhD, Aleksandra Klimczak, PhD, Emilia Jaskula, PhD, Michal Jelen, Andrzej Lange, Kazimierz Kuliczkowski

Blood (2006) 108 (11): 4644.

https://doi.org/10.1182/blood.V108.11.4644.4644

Published: 2006

NARROW

Analysis of CNV in the Genomes of the Marrow Cells of the Patients with AML Revealed That High Numbers of Aberrations Associate with Better Survival and Deletions with the Aberrant Expression of CD19 in the Leukemic Blasts

Intra Bone Route of Donor Lymphocyte Infusions May Result with an Anti-Leukemic Effect Associated with an Accumulation of CD279+ Lymphocytes in the Marrow

Sorafenib Is Contributing to Salvage Chemotherapy and Is Effective Given Alone for Maintenance in AML FLT3 ITD Patients Relapsing Post Allo Hematopoietic Stem Cell Transplantation

Essential Thrombocytosis Patients Have At Diagnosis Prevalence Of CD8+ and CD45RO+CCR7- Lymphocytes and High Proportions Of Double Positive IL-17+/CD15+ Cells In The Marrow Cell Population

CMV and EBV Reactivation Post HSCT Impairs Survival of Patients If They Do Not Produce IgM Antibodies Againts These Viruses

CCL2 Chemokine Gene Expression in Lymph Nodes May Have Prognostic Value in Non-Hodgkin’s Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

Analysis of CNV in the Genomes of the Marrow Cells of the Patients with AML Revealed That High Numbers of Aberrations Associate with Better Survival and Deletions with the Aberrant Expression of CD19 in the Leukemic Blasts

Intra Bone Route of Donor Lymphocyte Infusions May Result with an Anti-Leukemic Effect Associated with an Accumulation of CD279+ Lymphocytes in the Marrow

Sorafenib Is Contributing to Salvage Chemotherapy and Is Effective Given Alone for Maintenance in AML FLT3 ITD Patients Relapsing Post Allo Hematopoietic Stem Cell Transplantation

Essential Thrombocytosis Patients Have At Diagnosis Prevalence Of CD8+ and CD45RO+CCR7- Lymphocytes and High Proportions Of Double Positive IL-17+/CD15+ Cells In The Marrow Cell Population

CMV and EBV Reactivation Post HSCT Impairs Survival of Patients If They Do Not Produce IgM Antibodies Againts These Viruses

CCL2 Chemokine Gene Expression in Lymph Nodes May Have Prognostic Value in Non-Hodgkin’s Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only